Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label primary infant vaccination study of DTPa-IPV/Hib in China
2015-001513-27Phase 3
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of acthib + dpt-ipv in diphtheria, Tetanus, pertussis and 2 more (2 arms), sponsored by GSK. Primary endpoint: Safety and reactogenicity after each vaccine dose.
02
Drugs
acthib + dpt-ipv
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2015-001513-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001513-27.